关注
Kayla Holder
Kayla Holder
University of Colorado Denver | Anschutz Medical Campus
在 cuanschutz.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Dendritic cells enter lymph vessels by hyaluronan-mediated docking to the endothelial receptor LYVE-1
LA Johnson, S Banerji, W Lawrance, U Gileadi, G Prota, KA Holder, ...
Nature immunology 18 (7), 762-770, 2017
1682017
Hepatitis C virus–infected cells downregulate NKp30 and inhibit ex vivo NK cell functions
KA Holder, SN Stapleton, ME Gallant, RS Russell, MD Grant
The Journal of Immunology 191 (6), 3308-3318, 2013
762013
Rapid Lymphatic Dissemination of Encapsulated Group A Streptococci via Lymphatic Vessel Endothelial Receptor-1 Interaction
NN Lynskey, S Banerji, LA Johnson, KA Holder, M Reglinski, PAC Wing, ...
PLoS pathogens 11 (9), e1005137, 2015
452015
Origins of natural killer cell memory: special creation or adaptive evolution
KA Holder, EM Comeau, MD Grant
Immunology 154 (1), 38-49, 2018
232018
Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection
KA Holder, DP Ings, DOA Harnum, RS Russell, MD Grant
NPJ vaccines 7 (1), 122, 2022
192022
TIGIT blockade enhances NK cell activity against autologous HIV‐1‐infected CD4+ T cells
KA Holder, K Burt, MD Grant
Clinical & Translational Immunology 10 (10), e1348, 2021
182021
TIGIT blockade: a multipronged approach to target the HIV reservoir
KA Holder, MD Grant
Frontiers in cellular and infection microbiology 10, 175, 2020
182020
Human cytomegalovirus IL-10 augments NK cell cytotoxicity
KA Holder, MD Grant
Journal of leukocyte biology 106 (2), 447-454, 2019
182019
Natural killer cell function and dysfunction in hepatitis C virus infection
KA Holder, RS Russell, MD Grant
BioMed research international 2014 (1), 903764, 2014
162014
Natural killer cells adapt to cytomegalovirus along a functionally static phenotypic spectrum in human immunodeficiency virus infection
KA Holder, J Lajoie, MD Grant
Frontiers in Immunology 9, 2494, 2018
142018
Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2Cnull Human Immunodeficiency Virus-Infected Individuals
EM Comeau, KA Holder, NJ Fudge, MD Grant
Viruses 11 (3), 239, 2019
122019
Few SARS-CoV-2 infections detected in Newfoundland and Labrador in the absence of Public Health Laboratory-based confirmation
DP Ings, KM Hatfield, KE Fifield, DOA Harnum, KA Holder, RS Russell, ...
Plos one 17 (1), e0262957, 2022
82022
Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2
MD Grant, K Bentley, CA Fielding, KM Hatfield, DP Ings, D Harnum, ...
JCI insight 8 (15), 2023
72023
Modulation of the strength and character of HIV-specific CD8+ T cell responses with heteroclitic peptides
KA Holder, MD Grant
AIDS Research and Therapy 14, 1-4, 2017
42017
Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals
NJ Norton, KA Holder, DP Ings, DOA Harnum, RS Russell, MD Grant
Viruses 15 (4), 996, 2023
32023
Characteristics of Vaccine-and Infection-Induced Systemic IgA Anti-SARS-CoV-2 Spike Responses
NJ Norton, DP Ings, KE Fifield, DA Barnes, KA Barnable, DOA Harnum, ...
Vaccines 11 (9), 1462, 2023
22023
Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies
MD Grant, K Bentley, CA Fielding, KM Hatfield, DP Ings, D Harnum, ...
BioRxiv, 2023.03. 09.531709, 2023
12023
Progress towards World Health Organization HIV Infection 95-95-95 measures in Newfoundland and Labrador, Canada
KA Holder, E Ding, D Kao, M Shokoohi, J Trigg, RS Hogg, J Morkar, ...
PloS one 19 (6), e0305898, 2024
2024
Antibody ‘Hotspots’ induce antibody-dependent cell-mediated cytotoxicity against SARS-CoV-2 spike-expressing lung fibroblasts
K Holder, K Hatfield, D Ings, K Fifield, D Harnum, M Grant
The Journal of Immunology 208 (1_Supplement), 50.21-50.21, 2022
2022
The influence of TIGIT on natural killer cell activity against HIV
K Holder, M Grant
The Journal of Immunology 204 (1_Supplement), 95.12-95.12, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20